CD36 and Insulin resistance: T2DM related to factors such as insulin resistance, high oxLDL, systemic low-grade inflammation, or hepatosteatosis, stimulates CD36 expression in monocytes and macrophages localized in adipose tissue, the liver, and arteries leading to elevated plasma sCD36.